Stroke Diagnostics and Treatment Market Research Report, By Type, Application and Geography – Global Market Share, Trend Analysis and Forecast up to 2023

Report Code: 1331
Publish Date: September 2017

  Corporate License($4200)

  Single User License($3700)

Product Description

Global Stroke Diagnostics and Treatment Market is mainly segmented on the basis of type, application and by region/country. On the basis of type, the market is segmented into diagnostics and treatment market segments. The stroke diagnostics segment includes magnetic resonance imaging (MRI), computed tomography scan, electrocardiography, carotid ultrasound, cerebral angiography and others. The stroke treatment market segment includes tissue plasminogen activator, antiplatelet, antihypertensive and anticoagulants. By type of application, the market is segmented as ischemic stroke and hemorrhagic stroke. The report includes market size estimation for the regions such as Americas, Europe, Asia-Pacific and Middle East and Africa.

The global stroke diagnostics and treatment market revenue (in USD million) is estimated and forecasted from 2017 to 2023. The global market is anticipated to grow at a CAGR between 7.0% to 7.5% from 2018 to 2023. The factor driving the global stroke treatment and diagnostics devices market are Increasing obese population, growing prevalence rate of diabetes, growing addiction of tobacco etc.

Key companies which lead the stroke diagnostics and treatment market are Abbott Laboratories, Covidien plc, GE Healthcare, Hitachi, Ltd., Johnson & Johnson, Penumbra, Inc., Philips Healthcare, Siemens Healthcare, Stryker Corporation among others

According to CDC, NCHS, in the United States, more than 130,000 die every year due to stroke. About Every year, more than 795,000 people have a stroke. About 610,000 of these are first or new strokes. According to World Health Federation, yearly, 15 million people worldwide affected by a stroke. About 6 million people die and 5 million are left forever disabled. Globally stroke is the second leading cause of disability, after dementia.

Request sample report..
Axiom MRC estimates and forecast the market size through its Qual-Quant data modeling tool. It is an in-house developed tool, which is based on the fundamentals such as Top Down and Bottom Up approaches. The data model compares various related markets of stroke diagnostics and treatment market such as cardiovascular disease drugs and devices, obesity, diabetes, health & wellness equipments etc. markets to estimate and validate the qualitative and quantitative findings across various countries. It also allows to analyze the market value chain comparison with main market i.e. global CVD market to arrive at holistic and factual findings of the markets. The macro-indicator impacts analysis was also conducted, to find out various countries stroke diagnostics and treatment market. The outcome of the data collection and secondary research is further validated with in-depth primary interviews conducted with key industry participants of cardiovascular diseases market. Various free and paid sources are used during the secondary research phase. Sources used were Free sources - CVD devices and drugs manufacturers associations, key company web sites, annual reports, journals, press releases, Eurostat, WHO, U.S. FDA etc. Paid sources such as Factiva, Bloomberg, One Source etc. were also used. Extensive Primary research is conducted to bring insights into the key industry trends, new technologies, and future outlook of the market. All findings are verified and validated by the industry experts and subject matter experts which typically include: • Ceos/Cmos Of The Key CVD Drugs & Devices Manufacture Company • Key Opinion Leaders Such As Research Experts, Consultants, Knowledge Professionals & Others • Managers & Top Executives Of Key Companies • Suppliers & Manufacturers Of Raw Materials & Components • End Users i.e. Hospitals, Laboratories, Academic Institutes etc.